Feb. 21, 2024 — Scientists have found a way to predict Alzheimer's Disease up to seven years before symptoms appear by analyzing patient records with machine ...
Feb. 20, 2024 — Researchers have found that inhibiting a key protein can stop the destruction of synapses and dendritic spines commonly seen in Alzheimer's ...
A new study has laid the groundwork for a future intervention designed to help caregivers establish a safe and workable mealtime routine for people with dementia living at home.
Three recently developed drugs—lecanemab (Leqembi), aducanumab (Aduhelm), and donanemab—each target a different form of amyloid plaque in the brain.
Researchers at the Center for Alzheimer’s Disease Research are examining how risk factors and neuropsychiatric patterns may hold the key for early detection, and early intervention, in this fast-growing disease.
The history of frontotemporal dementia (FTD) is both old and new. This study explores its historical roots, dating back to the 19th century, while recognizes it as a distinct neurological entity only a few decades ago.
Brite Trace Foundation is a not-for-profit 501(c)(3) organization.
Copyright © 2024 Brite Trace Foundation - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.